Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management

Multiple myeloma is the second-most common hematologic malignancy in adults worldwide. Despite ongoing advancement in therapeutic modalities, it remains an incurable disease with a 5-year survival rate of approximately 50%. The recent development and introduction of anti-BCMA immunotherapies into cl...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Mariam Markouli, Fauzia Ullah, Serhan Unlu, Najiullah Omar, Nerea Lopetegui-Lia, Marissa Duco, Faiz Anwer, Shahzad Raza, Danai Dima
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2023-07-01
Serija:	Current Oncology
Teme:	CAR T-cell therapy bispecific antibodies cytokine release syndrome neurotoxicity hematotoxicity infections
Online dostop:	https://www.mdpi.com/1718-7729/30/7/467
Oznake:	Označite Brez oznak, prvi označite!